Coronary and peripheral arterial stenting with drug-eluting platforms — the metallic scaffolds delivering antiproliferative agents (sirolimus, paclitaxel, everolimus, zotarolimus) to prevent restenosis representing the dominant intervention in arterial revascularization — creates the most commercially mature yet innovation-driven market segment, with the Arterial Stents Market...

The bioresorbable vascular scaffold market is gaining significant attention within the cardiovascular device industry due to its potential to transform the treatment of coronary artery disease. Unlike conventional metallic stents, bioresorbable vascular scaffolds provide temporary vessel support and gradually dissolve after completing their therapeutic function. This innovative approach aims to...

"Coronary Stents Market Summary: According to the latest report published by Data Bridge Market Research, the Coronary Stents Market The global Coronary Stents Treatment market was valued at USD 2.28 billion in 2024 and is expected to reach USD 4.29 billion by 2032, at a CAGR of 7.3%, during the forecast period Attaining maximum return on investment...

The global coronary stents market is set for steady expansion, rising from USD 37.5 billion in 2026 to USD 64.6 billion by 2036, reflecting a compound annual growth rate (CAGR) of 5.6%. Future Market Insights highlights that this trajectory is driven by the enduring worldwide prevalence of coronary artery disease and ongoing improvements in percutaneous coronary intervention (PCI)...

The global healthcare landscape is witnessing a transformative era in cardiac care, driven primarily by the rising prevalence of cardiovascular diseases (CVDs) and the rapid evolution of minimally invasive procedures. The Interventional Cardiology Devices Market is at the forefront of this evolution, offering advanced solutions for treating structural heart conditions, coronary artery...